deltatrials
Recruiting PHASE3 INTERVENTIONAL 2-arm NCT04821778

Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer

Cohort Study of Definitive Chemoradiotherapy for Esophageal or Esophagogastric Junction Cancer

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Conditions Chemoradiation Chemotherapy Effect Esophagogastric Junction Cancer Esophagus Cancer Immunotherapy Targeted Therapy
Interventions 5-FU Analog based chemotherapy Immunotherapy Nimotuzumab Paclitaxel based chemotherapy Platinum based chemotherapy Radiotherapy
Updated 8 times since 2021 Last updated: Jan 18, 2026 Started: Jan 1, 2002 Primary completion: Dec 31, 2030 Completion: Dec 31, 2030
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Chemoradiation and Chemotherapy Effect, this trial is actively recruiting participants. The trial is conducted by Cancer Institute and Hospital, Chinese Academy of Medical Sciences and has accumulated 8 data snapshots since 2002. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Apr 2021 – ~Sep 2022 · 17 months · monthly snapshotRecruiting~Sep 2022 – ~Dec 2022 · 3 months · monthly snapshotRecruiting~Dec 2022 – ~Oct 2023 · 10 months · monthly snapshotRecruiting~Oct 2023 – ~Jul 2024 · 9 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – ~Jan 2025 · 4 months · monthly snapshotRecruiting~Jan 2025 – ~Feb 2026 · 13 months · monthly snapshotRecruiting~Feb 2026 – present · 5 months · monthly snapshotRecruiting

Change History

8 versions recorded

  1. Feb 2026 — Present [monthly]

    Recruiting PHASE3

  2. Jan 2025 — Feb 2026 [monthly]

    Recruiting PHASE3

  3. Sep 2024 — Jan 2025 [monthly]

    Recruiting PHASE3

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE3

  5. Oct 2023 — Jul 2024 [monthly]

    Recruiting PHASE3

▶ Show 3 earlier versions

  1. Dec 2022 — Oct 2023 [monthly]

    Recruiting PHASE3

  2. Sep 2022 — Dec 2022 [monthly]

    Recruiting PHASE3

  3. Apr 2021 — Sep 2022 [monthly]

    Recruiting PHASE3

    First recorded

Jan 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Data source: Cancer Institute and Hospital, Chinese Academy of Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations